HOXA11-AS and ovarian cancer: It was suggested that the regulation of some long non-coding RNAs, such as HOTAIR, UCA1, HOXA11AS, etc., through RNAi techniques or CRISPR/Cas-9 was thought to be a promising therapy for ovarian cancer (32).